Alexza Pharmaceuticals Inc. Contracts & Agreements

AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on June 24, 2016)

AMENDMENT NO. 2 TO LICENSE AND SUPPLY AGREEMENT (RESTRUCTURING) (Filed With SEC on May 13, 2016)

AMENDED AND RESTATED PROMISSORY NOTE AND AGREEMENT TO LEND (Filed With SEC on May 13, 2016)

ALEXZA PHARMACEUTICALS, INC. STOCK ISSUANCE AGREEMENT (Filed With SEC on May 13, 2016)

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN ALEXZA PHARMACEUTICALS, INC. AND TEVA PHARMACEUTICALS USA, INC. Dated as of February 23, 2016 1 (Filed With SEC on May 13, 2016)

AGREEMENT AND PLAN OF MERGER BYAND AMONG GRUPO FERRER INTERNACIONAL, S.A., FERRER PHARMA INC. AND ALEXZA PHARMACEUTICALS, INC. DATED AS OF MAY 9, 2016 TABLE OF CONTENTS (Filed With SEC on May 10, 2016)

AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on May 10, 2016)

Underlying Asset (Filed With SEC on April 29, 2016)

PROMISSORY NOTE (Filed With SEC on April 15, 2016)

PROMISSORY NOTE (Filed With SEC on March 24, 2016)

PROMISSORY NOTE (Filed With SEC on September 28, 2015)

ALEXZA PHARMACEUTICALS, INC. STOCK ISSUANCE AGREEMENT (Filed With SEC on September 28, 2015)

FOURTH AMENDMENT TO COLLABORATION, LICENSE AND SUPPLY AGREEMENT (Filed With SEC on August 6, 2015)

AMENDMENT NO. 1 TO LICENSE AND SUPPLYAGREEMENT (Filed With SEC on August 6, 2015)

AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE AND AGREEMENT TO LEND (Filed With SEC on August 6, 2015)

CONFIDENTIAL RELEASEAGREEMENT (Filed With SEC on May 22, 2015)

AMENDMENT NO. 3 TOMANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on March 13, 2015)

SECOND AMENDMENT TO COLLABORATION, LICENSE AND SUPPLY AGREEMENT (Filed With SEC on March 13, 2015)

THIRDAMENDMENT TO THE COLLABORATION, LICENSE AND SUPPLY AGREEMENT (Filed With SEC on March 13, 2015)

ALEXZA PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on March 13, 2015)

ALEXZA PHARMACEUTICALS, INC. 2015 CASH BONUS PLAN (Filed With SEC on February 17, 2015)

INDENTURE dated as ofMarch 18, 2014 by and between ATLAS U.S. ROYALTY, LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK... (Filed With SEC on November 5, 2014)

AMENDED AND RESTATED PURCHASE OPTION AGREEMENT by and among ALEXZAPHARMACEUTICALS, INC., SYMPHONY ALLEGRO HOLDINGS LLC and SYMPHONY ALLEGRO,INC. Dated as of June 15, 2009 TABLE OF... (Filed With SEC on November 5, 2014)

INDENTURE dated as ofMarch 18, 2014 by and between ATLAS U.S. ROYALTY, LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK... (Filed With SEC on May 5, 2014)

ALEXZA PHARMACEUTICALS, INC. WARRANT dated as ofMarch 18, 2014 (Filed With SEC on May 5, 2014)

ALEXZA PHARMACEUTICALS, INC. 2014 CASH BONUS PLAN (Filed With SEC on January 24, 2014)

SUMMARY OF COMPENSATION ARRANGEMENTS WITH NON-EMPLOYEE DIRECTORS (Filed With SEC on November 6, 2013)

ALEXZA PHARMACEUTICALS, INC. 2005 NON-EMPLOYEE DIRECTORS STOCK OPTIONPLAN ADOPTED: DECEMBER 7, 2005 APPROVED BY STOCKHOLDERS: FEBRUARY 13, 2006 AMENDED: SEPTEMBER 23, 2010... (Filed With SEC on November 6, 2013)

LICENSE AND SUPPLY AGREEMENT (Filed With SEC on August 14, 2013)

CONVERTIBLE PROMISSORY NOTE AND AGREEMENT TO LEND (Filed With SEC on August 14, 2013)

ALEXZA PHARMACEUTICALS, INC. 2005 EQUITY INCENTIVE PLAN (Filed With SEC on May 22, 2013)

ALEXZA PHARMACEUTICALS, INC. 2005 NON-EMPLOYEE DIRECTORS STOCK OPTIONPLAN (Filed With SEC on May 22, 2013)

ALEXZA PHARMACEUTICALS, INC. 2013 CASH BONUS PLAN (Filed With SEC on April 2, 2013)

AMENDMENT TO LICENSE & DEVELOPMENT AGREEMENT (Filed With SEC on March 26, 2013)

COMMON STOCK PURCHASE AGREEMENT DATED AS OF JULY 20, 2012 BY AND BETWEEN ALEXZA PHARMACEUTICALS, INC. AND AZIMUTH OPPORTUNITY, L.P. TABLE OF CONTENTS (Filed With SEC on July 23, 2012)

ALEXZA PHARMACEUTICALS, INC. 2012 CASH BONUS PLAN (Filed With SEC on May 10, 2012)

PARTIAL LEASE TERMINATION AGREEMENT (Filed With SEC on March 12, 2012)

AMENDMENT NO.2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 12, 2012)

COLLABORATION, LICENSE AND SUPPLY AGREEMENT (Filed With SEC on March 12, 2012)

AMENDMENT TO COLLABORATION, LICENSE ANDSUPPLY AGREEMENT (Filed With SEC on March 12, 2012)

Alexza Pharmaceuticals, Inc. Common Stock and Warrants Underwriting Agreement dated February 17, 2012 JMP SECURITIES LLC (Filed With SEC on February 17, 2012)

ALEXZA PHARMACEUTICALS, INC. WARRANT dated as of February , 2012 (Filed With SEC on February 17, 2012)

Executive Officer (Filed With SEC on August 2, 2011)

ALEXZA PHARMACEUTICALS, INC. (Filed With SEC on May 3, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 3, 2011)

AZ-004 (Staccato loxapine). We are developing AZ-004 for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. In December 2009, we submitted an NDA... (Filed With SEC on March 15, 2011)

Name and Title Stock Option AwardsThomas B. King President and Chief Executive Officer 213,143James V. Cassella, Ph.D. Senior Vice President, Research and Development... (Filed With SEC on February 22, 2011)

Alexza Pharmaceuticals, Inc. ID: 77-0567768Notice of Grant of Stock Options 2091 Stierlin Courtand Option Agreement Mountain View, CA 94043 [Name] Option Number: [Number][Address]... (Filed With SEC on February 22, 2011)

Alexza Pharmaceuticals, Inc. 2005 Equity Incentive Plan OptionAgreement (Incentive Stock Option or Nonstatutory Stock Option) (Filed With SEC on February 22, 2011)

Alexza Pharmaceuticals, Inc. 2005 Equity Incentive Plan (Filed With SEC on February 22, 2011)

Current assets (Filed With SEC on November 9, 2010)

Exhibit Number (Filed With SEC on August 5, 2010)

Current assets (Filed With SEC on July 26, 2010)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on May 26, 2010)

AZ-004 (Staccato loxapine). We are developing AZ-004 for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. In December 2009, we submitted our... (Filed With SEC on March 9, 2010)

ALEXZA PHARMACEUTICALS, INC. (Filed With SEC on September 30, 2009)

ALEXZA PHARMACEUTICALS, INC. (Filed With SEC on August 26, 2009)

Financial Statements (Unaudited) (Filed With SEC on August 5, 2009)

2009 2010 Performance Based Incentive Program (Filed With SEC on June 26, 2009)

Exhibit Number (Filed With SEC on June 26, 2009)

Current assets (Filed With SEC on May 11, 2009)

AZ-004 (Staccato loxapine). We are developing AZ-004 for the acute treatment of agitation in patients with schizophrenia or bipolar disorder. We project a new drug application, or... (Filed With SEC on March 10, 2009)

INDEMNITY AGREEMENT (Filed With SEC on July 14, 2008)

Alexza Pharmaceuticals, Inc. 2005 Equity Incentive Plan (Filed With SEC on May 30, 2008)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2008)

STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 26, 2008)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 26, 2008)

AZ-004 (Staccato loxapine). We are developing AZ-004 for the treatment of acute agitation in patients with schizophrenia or bi-polar disorder. In March 2007, we announced positive... (Filed With SEC on March 17, 2008)

Current assets (Filed With SEC on November 1, 2007)

Current assets (Filed With SEC on August 13, 2007)

ALEXZA PHARMACEUTICALS, INC. (a Delaware corporation) 6,000,000 Shares of Common Stock PURCHASE AGREEMENT (Filed With SEC on April 27, 2007)

AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. In December 2006, we completed enrollment of an at-home 400... (Filed With SEC on March 29, 2007)

AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. According to the National Headache Foundation,... (Filed With SEC on February 15, 2006)

AZ-001 (Staccato prochlorperazine). We are developing AZ-001 to treat patients suffering from acute migraine headaches. According to the National Headache Foundation, over 13... (Filed With SEC on December 22, 2005)

Category

Industry

Companies

Contracts

Alexza Pharmaceuticals Inc. Contracts & Agreements